Complete our short form to continue

Genestack will process your personal data in accordance to its privacy policy which can be found here. This includes sending you updates by email about our products and content we think it would be of interest to you. You can unsubscribe at any time by clicking the link in the footer of any email we send. By clicking submit you agree that we process your information in accordance with these terms.
Company

A genome for $100 could be a reality

15.02.17
"Misha Kapushesky, founder of Cambridge-based Genestack, speaking to Cambridge Business magazine, said of the increasingly available dataset: "As a proportion of genomics and sequencing the production costs are going down - it's getting cheaper - and data management is going up. The progression of this technology goes in leaps and bounds. The last leap was six or seven years ago which was NGS - next-generation sequencing. That allowed David Cameron to announce the 100,000 Genome Project." This project meant 100,000 UK patients with cancer and rare diseases had their entire genome decoded, leading to targeted therapies which could make chemotherapy "a thing of the past"." Read full article here
15.02.17

Sign up for our newsletter